NASDAQ Composite ended the session with Bionano Genomics jumping 2.09% to $5.38 on Tuesday, after four successive sessions in a row of losses. NASDAQ Composite dropped 0.92% to $13,786.27, following last session’s downward trend on what was a somewhat rough trend exchanging session today.
Bionano Genomics today’s close was $5.38, 191.64% below its 52-week high of $15.69.
Bionano Genomics’s Sales
Bionano Genomics’s sales growth is 160.5% for the ongoing quarter and 203.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 86.7% and 44.4%, respectively.
Bionano Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.5M for the twelve trailing months.
Bionano Genomics’s last day, last week, and last month’s current volatility was 7.40%, 5.99%, and 5.26%, respectively.
Bionano Genomics‘s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 11.33% (day), 8.60% (last week), and 8.63% (last month), respectively.
Bionano Genomics’s Stock Yearly Top and Bottom Value
Bionano Genomics’s stock is valued at $5.38 at 17:05 EST, way below its 52-week high of $15.69 and way above its 52-week low of $0.28.
Bionano Genomics’s Moving Average
Bionano Genomics’s worth is way under its 50-day moving average of $9.47 and way higher than its 200-day moving average of $4.64.
More news about Bionano Genomics.